15 August 2024
|
min read

In this article for Insurance Innovation Reporter, Genomics plc Co-Founder and CEO Sir Peter Donnelly addresses common misconceptions around genetic risk testing and outlines the potential benefits for insurers. He explains how polygenic risk scores can be used responsibly to improve risk prediction, enhance customer trust, and support better health outcomes.
This article was published in Insurance Innovation Reporter.